Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR+7.9%
5Y CAGR-17.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+7.9%/yr
vs -6.5%/yr prior
5Y CAGR
-17.0%/yr
Recent acceleration
Acceleration
+14.4pp
Accelerating
Percentile
P80
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 21.94% |
| Q2 2025 | 9.89% |
| Q1 2025 | -103.32% |
| Q4 2024 | 2.24% |
| Q3 2024 | -15.87% |
| Q2 2024 | 32.17% |
| Q1 2024 | 9.09% |
| Q4 2023 | 19.31% |
| Q3 2023 | -14.94% |
| Q2 2023 | 23.97% |
| Q1 2023 | -7.43% |
| Q4 2022 | -11.10% |
| Q3 2022 | 17.45% |
| Q2 2022 | -1.40% |
| Q1 2022 | -12.70% |
| Q4 2021 | -31.78% |
| Q3 2021 | -1025.32% |
| Q2 2021 | 108.14% |
| Q1 2021 | -42.40% |
| Q4 2020 | -19.40% |
| Q3 2020 | 55.72% |
| Q2 2020 | 8.39% |
| Q1 2020 | -8.23% |
| Q4 2019 | -94.41% |
| Q3 2019 | 25.52% |
| Q2 2019 | 21.70% |
| Q1 2019 | -101.52% |
| Q4 2018 | -30.76% |
| Q3 2018 | -63.43% |
| Q2 2018 | 27.64% |
| Q1 2018 | 0.00% |